Regenerative Medicine in Urogynecology: Where We Are and Where We Want to Be
(Abstracted from Urogynecology (Phila) 2024;30:519–527) Current guidance on treatment for pelvic floor disorders revolves around anatomical correction and compensation for lost function rather than the underlying cause for the disorder. In contrast, regenerative medicine strategies using stem cells, extracellular vesicles, secretomes, laser therapies, platelet-rich plasma (PRP), and bioinductive acellular biomaterial scaffolds offer a different therapeutic approach.
Authors
- Karen L. Christman (ORCID: https://orcid.org/0000-0002-6179-898X)
- Marianna Alperin (ORCID: https://orcid.org/0000-0002-6004-1803)
- Tatyanna Henderson
Publication Details
- Journal
- Obstetrical & Gynecological Survey
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1097/ogx.0000000000001321
- Primary Topic
- Tissue Engineering and Regenerative Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00